| __timestamp | Dr. Reddy's Laboratories Limited | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 612613000000 |
| Thursday, January 1, 2015 | 42585000000 | 650773000000 |
| Friday, January 1, 2016 | 45702000000 | 619061000000 |
| Sunday, January 1, 2017 | 46372000000 | 628106000000 |
| Monday, January 1, 2018 | 46910000000 | 717599000000 |
| Tuesday, January 1, 2019 | 48890000000 | 964737000000 |
| Wednesday, January 1, 2020 | 50129000000 | 875663000000 |
| Friday, January 1, 2021 | 54559000000 | 886361000000 |
| Saturday, January 1, 2022 | 62081000000 | 997309000000 |
| Sunday, January 1, 2023 | 105931000000 | 1053819000000 |
| Monday, January 1, 2024 | 77201000000 | 1053819000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Takeda Pharmaceutical Company Limited and Dr. Reddy's Laboratories Limited, two industry titans, have shown contrasting approaches over the past decade. From 2014 to 2023, Takeda's SG&A expenses have consistently been higher, peaking at over 1 trillion yen in 2023, reflecting their expansive global operations. In contrast, Dr. Reddy's Laboratories maintained a more conservative approach, with expenses reaching approximately 106 billion yen in the same year. This disparity highlights Takeda's aggressive market strategies compared to Dr. Reddy's more streamlined operations. Despite the differences, both companies have shown a steady increase in SG&A costs, emphasizing the growing complexity and competition in the pharmaceutical sector. As we look to 2024, the question remains: will these trends continue, or will strategic shifts alter the landscape?
Amgen Inc. or Takeda Pharmaceutical Company Limited: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Sanofi vs Dr. Reddy's Laboratories Limited
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Neurocrine Biosciences, Inc. Trends and Insights
Selling, General, and Administrative Costs: Takeda Pharmaceutical Company Limited vs Rhythm Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Takeda Pharmaceutical Company Limited and Agios Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited or Dynavax Technologies Corporation: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
Intra-Cellular Therapies, Inc. and Dr. Reddy's Laboratories Limited: SG&A Spending Patterns Compared
Dr. Reddy's Laboratories Limited vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Dr. Reddy's Laboratories Limited and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Evotec SE